Internal Medicine, Hepatology · New Orleans, LA
NPI
1346327822
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Highway
New Orleans, LA, 70121
Phone (504) 842-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
250 services
Medicare patients, 2024
165
Average age 69
Drug cost, 2024
$854K
2,125 prescriptions
Company payments, 2025
$15K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shobha N Joshi was code 99214 (office e&m - established), 46 times for 40 patients. In total Shobha N Joshi billed 250 services in 14 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 46 | 40 | $67.35 | $3,098 |
| 99223 Hospital E&M - Initial | Facility | 31 | 31 | $129.80 | $4,024 |
| 99214 Office E&M - Established | Office | 27 | 27 | $87.49 | $2,362 |
| 99215 Office E&M - Established | Office | 25 | 23 | $123.13 | $3,078 |
| 99232 Hospital E&M - Subsequent | Facility | 21 | 15 | $60.02 | $1,260 |
| 99213 Office E&M - Established | Facility | 16 | 16 | $46.64 | $746 |
| 99213 Office E&M - Established | Office | 15 | 13 | $56.60 | $849 |
| 99215 Office E&M - Established | Facility | 13 | 12 | $103.35 | $1,344 |
By year: 2022 $22K for 280 services; 2023 $20K for 284 services; 2024 $21K for 250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shobha N Joshi prescribed most often to Medicare patients was Tacrolimus, with 470 prescriptions and refills. In total Shobha N Joshi wrote 2,125 Medicare prescriptions that cost $854K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 470 | 631 | 69 | $40K |
| Mycophenolate Mofetil Generic | 214 | 300 | 34 | $19K |
| Ursodiol Generic | 208 | 307 | 44 | $22K |
| Lamivudine Generic | 122 | 180 | 17 | $11K |
| Entecavir Generic | 119 | 127 | 11 | $14K |
| Xifaxan Rifaximin | 112 | 124 | 27 | $396K |
| Spironolactone Generic | 92 | 145 | 22 | $850 |
| Furosemide Generic | 78 | 155 | 24 | $209 |
| Lactulose Generic | 56 | 62 | 17 | $2,535 |
| Cyclosporine Modified Cyclosporine, Modified | 49 | 65 | Under 11 | $5,993 |
| Sirolimus Generic | 43 | 75 | Under 11 | $16K |
| Mycophenolic Acid Mycophenolate Sodium | 37 | 49 | Under 11 | $1,228 |
| Vemlidy Tenofovir Alafenamide | 31 | 31 | Under 11 | $45K |
| Prednisone Generic | 30 | 32 | 11 | $171 |
| Carvedilol Generic | 27 | 55 | 11 | $122 |
Brand drugs: 235 claims; generic drugs: 1,890 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shobha N Joshi $15K ($13K in general payments such as food, travel and fees and $1,843 for research) from 4 companies. The largest payer was Gilead Sciences, Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.